Clinical and translational results from REVOLUTION cohorts A (nivolumab + ipilimumab + chemotherapy) and B (hydroxychloroquine + ipilimumab + chemotherapy) in patients with previously untreated metastatic pancreatic adenocarcinoma Meeting Abstract
| Authors: | O'Reilly, E. M.; Wainberg, Z. A.; Fisher, G. A. Jr; Wolff, R. A.; Ko, A. H.; O'Hara, M. H.; Spencer, C. N.; Yu, J. X.; Da Silva, D. M.; Padron, L. J.; Lyman, J. P.; Moore, J. S.; Peng, B.; Hoos, W.; O'Donnell-Tormey, J.; Boffo, S.; Dugan, U.; Cabanski, C. R.; Amaravadi, R. K.; Vonderheide, R. H. |
| Abstract Title: | Clinical and translational results from REVOLUTION cohorts A (nivolumab + ipilimumab + chemotherapy) and B (hydroxychloroquine + ipilimumab + chemotherapy) in patients with previously untreated metastatic pancreatic adenocarcinoma |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401107 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.4137 |
| Notes: | Meeting Abstract: 4137 -- Source: Wos |
